We have a problem with current recommendations for depression treatment. Many patients will not get any relief from first line...
Read moreHealth policy today seems hell bent on reviving the days of yellow journalism, where sensationalization was the calling card for...
Read moreCoughs are everywhere this time of the year. They appear to be both harmless yet persistent, which make coughs particularly...
Read moreCompulsive buying during the holiday season can have significant impacts on individuals' mental health and financial well-being.
Read moreTo support those who might not be aware of their anxieties, we shed light on ten less recognized symptoms and...
Read moreWe aim to shed light on the factors that contribute to the loss of credibility in patients and how these...
Read moreData on addiction and overdoses are notoriously weak. They're subject to varying interpretations. We need to study the lived experiences...
Read moreWe reflect on our experiences at the recent Association of Health Care Journalists conference in St. Louis.
Read moreMost abortion laws default to restricting access. But making a clinical behavior more difficult to accomplish does not deter it.
Read moreWe dive into the cognitive dissonance physicians face when challenging false narratives surrounding the opioid epidemic.
Read moreFear affects healthcare in curious ways, turning worst case scenarios into looming inevitabilities. We compare the fear in the COVID-19...
Read moreThe now month old behavior of the artist reveals a complex reality at the intersection of black history and mental...
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy